Premium
Acute Respiratory Distress Syndrome: Use of Specialized Nutrients in Pediatric Patients and Infants
Author(s) -
Hamilton Leslie A.,
Trobaugh Kimberly A.
Publication year - 2011
Publication title -
nutrition in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.725
H-Index - 71
eISSN - 1941-2452
pISSN - 0884-5336
DOI - 10.1177/0884533610392922
Subject(s) - medicine , ards , acute respiratory distress , intensive care medicine , mechanical ventilation , respiratory distress , eicosapentaenoic acid , mortality rate , pediatrics , lung , surgery , polyunsaturated fatty acid , fatty acid , chemistry , organic chemistry
With a high rate of mortality, acute respiratory distress syndrome (ARDS) has limited treatments options. Immune‐enhanced formulas, containing eicosapentaenoic acid, borage oil, and antioxidants, have shown to be beneficial in adults patients with ARDS, decreasing mortality, length of mechanical ventilation, and new organ dysfunction. There is promising research in pediatric patients with improvement in oxygenation status found, but further trials are needed to realize these benefits in pediatric and infant populations.